The Female Health Company Featured in Documentary Television Series "Big Questions"
February 18 2016 - 8:30AM
The Female Health Company (NASDAQ:FHCO) (FHC or the Company) today
announced that it will be featured in an upcoming episode of "Big
Questions," an Emmy® Award winning documentary television series
that explores new ideas and projects that are changing the way the
world works. The episode “Empowering Kenya” focuses on the
critical roles the Company and its FC2 Female Condoms play in
preventing the spread of HIV/AIDS, the leading cause of death
globally for women ages 15 to 44, and other sexually transmitted
infections. “Empowering Kenya” will be featured on WTTW/PBS
in Chicago at 10:30 PM CT on February 19, 2016, check your local
listings for dates and times in your area. The episode will
also be available to view online after the broadcast.
The documentary includes interviews with key
members of Kenya’s Ministry of Health, the United Nations Fund for
Population Activities (UNFPA) and the Muthaa Community Development
Foundation, as well as O.B. Parrish, CEO of FHC and other current
and former FHC executives: Mary Ann Leeper, Karen King and Denise
Van Dijk.
“We are extremely pleased that "Big Questions" and
PBS are bringing much needed attention and awareness to the health
epidemic that is occurring in Kenya,” said Parrish. “While
Kenya serves as a case study for the documentary, the issues raised
in the film affect many countries around the world. In fact,
more than 215 million women globally still do not have access to
contraceptives and women contract more than half of all new HIV
infections.
“For more than 20 years, FHC has been dedicated to
improving the health and well-being of women around the
world. FC2 helps protect against unintended pregnancies, an
ongoing major health and economic issue worldwide, with adolescents
accounting for a disproportionate percentage of the overall burden
of disease (disability - adjusted life years) associated with
pregnancy and childbirth. And, more recently, we are working
closely and actively engaging with leading health organizations
throughout the world, especially North America and South America,
regarding the Zika virus. Our goal is to provide information
and options to effectively protect women from sexually transmitted
infections.
“The emergence of the Zika virus subsequent to the
production of the documentary has dramatically increased the need
for access to female condoms.”
As the only available female-controlled method of
protection from sexually transmitted infections, including
HIV/AIDS, and unplanned pregnancy, the female condom brings
empowerment and choice to women, as well as the ability to better
negotiate safer sex and take charge of their own protection against
sexually transmitted infections (STIs). The Centers for
Disease Control and Prevention (CDC) estimates the number of new
STIs in the United States at 19 million annually. In the
U.S., more than an estimated 24,000 women each year lose the
ability to conceive or carry a pregnancy to term due to undiagnosed
or untreated STIs.
FC2, manufactured by The Female Health Company, is
the only female condom in the world with U.S. Food and Drug
Administration approval as well as clearance from the World Health
Organization.
About The Female Health
Company
The Female Health Company, based in Chicago,
Illinois, manufactures and markets the FC2 Female Condom® (FC2).
Since the Company began distributing FC2 in 2007, the product has
been shipped to 144 countries. The Company owns certain worldwide
rights to the FC2 Female Condom®, including patents that have been
issued in a number of countries around the world. The patents cover
key aspects of FC2, including its overall design and manufacturing
process. The FC2 Female Condom® is the only currently
available female-controlled product approved by the FDA that offers
dual protection against sexually transmitted infections, including
HIV/AIDS, and unintended pregnancy. The World Health Organization
(WHO) has cleared FC2 for purchase by U.N. agencies.
For more information about The Female Health
Company visit the Company's website at http://www.femalehealth.com
and http://www.femalecondom.org. If you would like to be added to
the Company's e-mail alert list, please send an e-mail to
FHCInvestor@femalehealthcompany.com
Contacts:
William R. Gargiulo, Jr. 231.526.1244
Michele Greco, CFO 312.595.9123
Veru (NASDAQ:VERU)
Historical Stock Chart
From May 2024 to Jun 2024
Veru (NASDAQ:VERU)
Historical Stock Chart
From Jun 2023 to Jun 2024